Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARHGAP28 antisense RNA 1 (ARHGAP28-AS1) is a long non-coding RNA (lncRNA) gene located in the human genome. Antisense RNAs such as ARHGAP28-AS1 typically regulate the expression of nearby protein-coding genes, often through mechanisms including RNA-RNA interactions or chromatin modification, but specific functions or disease associations for this RNA remain uncharacterized in the present literature. It should not be confused with the protein-coding ARHGAP28 gene, which encodes a Rho GTPase-activating protein involved in regulation of actin cytoskeleton, cell migration, and potentially in tumor suppression. No clinical drugs, biomarker roles, or established therapeutic mechanisms are documented for ARHGAP28-AS1.\n\nIf you are seeking information on the protein-coding ARHGAP28 (Rho GTPase activating protein 28), please clarify, as that molecule is better characterized in cell biology and disease contexts.
Not applicable (no drugs known to target ARHGAP28-AS1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARHGAP28 antisense RNA 1 (ARHGAP28-AS1).